The Institute for Stem Cell Science & Regenerative Medicine, Bangalore is an autonomous institute under the Department of Biotechnology, Ministry of Science & Technology, Government of India. BRIC-inStem’s mandate is to establish collaborative research programs in the field of stem cell biology, regeneration, and repair in development and disease, with an emphasis on translation. To develop strengths in focused areas, research at BRIC-inStem is driven through collaborative interdisciplinary teams, addressing questions that are beyond the scope of a single laboratory.

Researchers have identified a synthetic peptide that may offer a new approach to studying and modulating the biological processes associated with Alzheimer’s disease. The compound, known as P33, reduced amyloid-beta (Aβ) levels and amyloid plaque burden in mice engineered to develop Alzheimer’s-like pathology, according to a study published in Bioorganic Chemistry.